ESSA Pharma Stock Price, News & Analysis (NASDAQ:EPIX)

$0.19 -0.01 (-3.05 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$0.19
Today's Range$0.19 - $0.20
52-Week Range$0.15 - $3.59
Volume90,175 shs
Average Volume171,887 shs
Market Capitalization$22.64 million
P/E Ratio-1.27
Dividend YieldN/A
BetaN/A

About ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma logoESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EPIX
CUSIPN/A
Phone778-331-0962

Debt

Debt-to-Equity Ratio-0.84%
Current Ratio0.62%
Quick Ratio1.26%

Price-To-Earnings

Trailing P/E Ratio-1.27333333333333
Forward P/E Ratio-0.66
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.22) per share
Price / Book-0.87

Profitability

Trailing EPS($0.15)
Net Income$-4,720,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-216.78%

Miscellaneous

Employees15
Outstanding Shares29,100,000

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc. (NASDAQ:EPIX) issued its quarterly earnings results on Monday, December, 11th. The company reported ($0.09) earnings per share (EPS) for the quarter. View ESSA Pharma's Earnings History.

When will ESSA Pharma make its next earnings announcement?

ESSA Pharma is scheduled to release their next quarterly earnings announcement on Monday, May, 21st 2018. View Earnings Estimates for ESSA Pharma.

Where is ESSA Pharma's stock going? Where will ESSA Pharma's stock price be in 2018?

3 Wall Street analysts have issued 1 year price objectives for ESSA Pharma's shares. Their predictions range from $9.00 to $9.00. On average, they expect ESSA Pharma's stock price to reach $9.00 in the next year. View Analyst Ratings for ESSA Pharma.

Who are some of ESSA Pharma's key competitors?

How do I buy ESSA Pharma stock?

Shares of ESSA Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of ESSA Pharma stock can currently be purchased for approximately $0.19.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $22.64 million. The company earns $-4,720,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis. ESSA Pharma employs 15 workers across the globe.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962.


MarketBeat Community Rating for ESSA Pharma (EPIX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about ESSA Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ESSA Pharma (NASDAQ:EPIX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.673.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.00$9.00$9.00$9.00
Price Target Upside: 3,813.04% upside3,813.04% upside2,854.69% upside2,850.82% upside

ESSA Pharma (NASDAQ:EPIX) Consensus Price Target History

Price Target History for ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma (NASDAQ:EPIX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/18/2018Bloom BurtonUpgradeHold -> BuyHighView Rating Details
8/3/2017Dawson JamesReiterated RatingBuyHighView Rating Details
2/17/2017Noble FinancialInitiated CoverageBuy$9.00N/AView Rating Details
(Data available from 2/17/2016 forward)

Earnings

ESSA Pharma (NASDAQ:EPIX) Earnings History and Estimates Chart

Earnings by Quarter for ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma (NASDAQ EPIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/21/2018        
12/11/2017Q4 2017($0.09)ViewN/AView Earnings Details
8/14/2017Q3 2017($0.17)($0.16)ViewN/AView Earnings Details
5/15/2017Q2 2017($0.11)($0.26)ViewN/AView Earnings Details
2/13/2017Q1 2017$0.05ViewN/AView Earnings Details
12/14/2016Q4 2016($0.19)ViewN/AView Earnings Details
8/12/2016Q3 2016($0.13)ViewN/AView Earnings Details
5/13/2016Q2 2016($0.20)ViewN/AView Earnings Details
2/12/2016Q1 2016($0.18)ViewN/AView Earnings Details
12/14/2015Q4 2015$0.02ViewN/AView Earnings Details
8/17/2015Q3 2015($0.28)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

ESSA Pharma (NASDAQ:EPIX) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.29 EPS
Next Year EPS Consensus Estimate: $-0.33 EPS

Dividends

Dividend History for ESSA Pharma (NASDAQ:EPIX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ESSA Pharma (NASDAQ EPIX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

ESSA Pharma (NASDAQ EPIX) News Headlines

Source:
DateHeadline
ESSA Pharma reports 1Q lossESSA Pharma reports 1Q loss
www.cnbc.com - February 14 at 8:36 AM
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017
finance.yahoo.com - February 13 at 5:04 PM
What Bargain Hunting? Bet on 6 Stocks With Rising P/EWhat Bargain Hunting? Bet on 6 Stocks With Rising P/E
finance.yahoo.com - February 7 at 8:32 AM
Zacks Investment Research Upgrades ESSA Pharma (EPIX) to "Buy"Zacks Investment Research Upgrades ESSA Pharma (EPIX) to "Buy"
www.americanbankingnews.com - February 6 at 11:06 PM
ESSA Pharma (EPIX) Cut to Hold at Zacks Investment ResearchESSA Pharma (EPIX) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - February 5 at 11:24 PM
 ESSA Pharma Inc. (EPIX) Given Consensus Rating of "Strong Buy" by Analysts ESSA Pharma Inc. (EPIX) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - February 1 at 1:12 AM
 ESSA Pharma Inc. (EPIX) Given $5.10 Average Target Price by Brokerages ESSA Pharma Inc. (EPIX) Given $5.10 Average Target Price by Brokerages
www.americanbankingnews.com - January 26 at 9:14 PM
ESSA to Present at Noble Capital Markets NobleCon14ESSA to Present at Noble Capital Markets' NobleCon14
finance.yahoo.com - January 26 at 8:33 AM
 ESSA Pharma Inc. (EPIX) Given Average Rating of "Buy" by Analysts ESSA Pharma Inc. (EPIX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - January 21 at 5:24 AM
ESSA Pharma (EPIX) Upgraded at Bloom BurtonESSA Pharma (EPIX) Upgraded at Bloom Burton
www.americanbankingnews.com - January 20 at 6:28 AM
ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price RuleESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule
www.prnewswire.com - January 16 at 10:19 PM
Zacks: ESSA Pharma Inc. (EPIX) Given Consensus Recommendation of "Buy" by AnalystsZacks: ESSA Pharma Inc. (EPIX) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 5 at 7:24 PM
 ESSA Pharma Inc. (EPIX) Receives Average Recommendation of "Buy" from Brokerages ESSA Pharma Inc. (EPIX) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - December 21 at 5:12 PM
 ESSA Pharma Inc. (EPIX) Given $5.10 Consensus Target Price by Analysts ESSA Pharma Inc. (EPIX) Given $5.10 Consensus Target Price by Analysts
www.americanbankingnews.com - December 5 at 11:36 PM
 ESSA Pharma Inc. (EPIX) Given $5.10 Average Price Target by Analysts ESSA Pharma Inc. (EPIX) Given $5.10 Average Price Target by Analysts
www.americanbankingnews.com - December 2 at 9:34 AM
 Analysts Anticipate ESSA Pharma Inc. (EPIX) to Post -$0.18 EPS Analysts Anticipate ESSA Pharma Inc. (EPIX) to Post -$0.18 EPS
www.americanbankingnews.com - November 22 at 3:16 AM
Zacks: ESSA Pharma Inc. (EPIX) Receives Consensus Recommendation of "Buy" from AnalystsZacks: ESSA Pharma Inc. (EPIX) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 16 at 3:36 PM
Zacks: Analysts Anticipate ESSA Pharma Inc. (EPIX) to Announce -$0.18 EPSZacks: Analysts Anticipate ESSA Pharma Inc. (EPIX) to Announce -$0.18 EPS
www.americanbankingnews.com - November 1 at 11:10 PM
 ESSA Pharma Inc. (EPIX) Given Average Recommendation of "Buy" by Analysts ESSA Pharma Inc. (EPIX) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - October 26 at 11:18 PM
Zacks: ESSA Pharma Inc. (EPIX) Receives Average Rating of "Buy" from AnalystsZacks: ESSA Pharma Inc. (EPIX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - October 23 at 2:06 AM
Brokerages Expect ESSA Pharma Inc. (EPIX) to Announce ($0.18) EPSBrokerages Expect ESSA Pharma Inc. (EPIX) to Announce ($0.18) EPS
www.americanbankingnews.com - October 16 at 12:08 AM
-$0.18 Earnings Per Share Expected for ESSA Pharma Inc. (EPIX) This Quarter-$0.18 Earnings Per Share Expected for ESSA Pharma Inc. (EPIX) This Quarter
www.americanbankingnews.com - October 13 at 10:26 PM
Zacks: ESSA Pharma Inc. (EPIX) Receives Consensus Rating of "Buy" from AnalystsZacks: ESSA Pharma Inc. (EPIX) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 5 at 6:24 PM
Analysts Anticipate ESSA Pharma Inc. (EPIX) to Announce ($0.18) Earnings Per ShareAnalysts Anticipate ESSA Pharma Inc. (EPIX) to Announce ($0.18) Earnings Per Share
www.americanbankingnews.com - October 2 at 2:38 AM
ESSA Pharma (EPIX) Reports Results from Phase 1 Trial of EPI-506 for Treatment of mCRPC; Provides Update on Clinical and Strategic PlansESSA Pharma (EPIX) Reports Results from Phase 1 Trial of EPI-506 for Treatment of mCRPC; Provides Update on Clinical and Strategic Plans
www.streetinsider.com - September 13 at 7:43 PM
ESSA Pharma Inc. (EPIX) Lowered to Hold at Bloom BurtonESSA Pharma Inc. (EPIX) Lowered to Hold at Bloom Burton
www.americanbankingnews.com - September 13 at 7:18 PM
ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic PlansESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans
finance.yahoo.com - September 11 at 6:58 PM
ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 CongressESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress
finance.yahoo.com - September 7 at 6:26 PM
Essa Pharma Is More Likely To Fly Than To DieEssa Pharma Is More Likely To Fly Than To Die
seekingalpha.com - September 6 at 11:16 PM
ESSA Pharma to Present at Rodman & Renshaw 19th Annual Global Investment ConferenceESSA Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference
finance.yahoo.com - September 1 at 6:39 PM
Analysts Expect ESSA Pharma Inc. (EPIX) to Announce ($0.19) Earnings Per ShareAnalysts Expect ESSA Pharma Inc. (EPIX) to Announce ($0.19) Earnings Per Share
www.americanbankingnews.com - August 18 at 10:18 PM
ESSA Pharma posts 3Q profitESSA Pharma posts 3Q profit
www.cnbc.com - August 15 at 7:00 PM
 Analysts Set $5.10 Target Price for ESSA Pharma Inc. (EPIX) Analysts Set $5.10 Target Price for ESSA Pharma Inc. (EPIX)
www.americanbankingnews.com - August 14 at 6:12 PM
 ESSA Pharma Inc. (EPIX) Given Average Rating of "" by Brokerages ESSA Pharma Inc. (EPIX) Given Average Rating of "" by Brokerages
www.americanbankingnews.com - August 9 at 12:10 AM
ESSA Pharma Inc. (NASDAQ:EPIX) Receives "Buy" Rating from Dawson JamesESSA Pharma Inc. (NASDAQ:EPIX) Receives "Buy" Rating from Dawson James
www.americanbankingnews.com - August 8 at 7:00 AM
 ESSA Pharma Inc. (EPIX) Given $8.00 Average Target Price by Analysts ESSA Pharma Inc. (EPIX) Given $8.00 Average Target Price by Analysts
www.americanbankingnews.com - August 1 at 8:00 AM
ESSA Pharma (EPIX) to Delay Offering Until Results From Higher Dose in Phase 1 Trial of EPI-506ESSA Pharma (EPIX) to Delay Offering Until Results From Higher Dose in Phase 1 Trial of EPI-506
www.streetinsider.com - July 25 at 6:36 PM
ESSA Pharma Shares Spike on Delayed FinancingESSA Pharma Shares Spike on Delayed Financing
www.baystreet.ca - July 24 at 7:24 PM
ESSA Pharma Announces Update to Proposed Equity OfferingESSA Pharma Announces Update to Proposed Equity Offering
finance.yahoo.com - July 18 at 7:54 PM
ESSA Pharma (EPIX) Prices of Proposed Offering of Common Stock, WarrantsESSA Pharma (EPIX) Prices of Proposed Offering of Common Stock, Warrants
www.streetinsider.com - July 14 at 1:15 AM
ESSA Pharma Announces Pricing of Proposed Equity OfferingESSA Pharma Announces Pricing of Proposed Equity Offering
finance.yahoo.com - July 13 at 7:38 PM
ESSA Pharma Announces Overnight Marketed Equity OfferingESSA Pharma Announces Overnight Marketed Equity Offering
finance.yahoo.com - July 12 at 6:58 PM
ESSA Pharma Up on ASCO NewsESSA Pharma Up on ASCO News
www.baystreet.ca - May 19 at 8:01 AM
Boxer Capital, LLC Buys AveXis, BeiGene, Alnylam Pharmaceuticals, Sells Biomarin ...Boxer Capital, LLC Buys AveXis, BeiGene, Alnylam Pharmaceuticals, Sells Biomarin ...
www.nasdaq.com - February 17 at 5:48 PM
ESSA Pharma nabs $10M capital raise; shares down 11%ESSA Pharma nabs $10M capital raise; shares down 11%
seekingalpha.com - November 22 at 8:06 AM
ESSA Pharma reports 3Q lossESSA Pharma reports 3Q loss
www.cnbc.com - August 12 at 4:55 PM
ESSA Pharma reports 3Q lossESSA Pharma reports 3Q loss
www.cnbc.com - August 12 at 4:55 PM

SEC Filings

ESSA Pharma (NASDAQ:EPIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

ESSA Pharma (NASDAQ:EPIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ESSA Pharma (NASDAQ EPIX) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.